Ignite Creation Date:
2025-12-24 @ 1:41 PM
Ignite Modification Date:
2025-12-29 @ 9:34 PM
Study NCT ID:
NCT01704495
Status:
COMPLETED
Last Update Posted:
2016-03-01
First Post:
2012-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-09
First Submit QC Date:
None
Study First Post Date:
2012-10-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-06-30
Results First Submit QC Date:
None
Results First Post Date:
2016-03-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-02-01
Last Update Post Date:
2016-03-01
Last Update Post Date Type:
ESTIMATED